FDA Approved: DIHYDROERGOTAMINE MESYLATE — Original Application (Baxter Healthcare Corporation)

View source ↗

Summary

The FDA approved Baxter Healthcare Corporation's dihydroergotamine mesylate as an original ANDA generic product. The approval covers the generic formulation of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Dihydroergotamine mesylate (Dihydroergotamine Mesylate)

Snippet

ORIG AP for DIHYDROERGOTAMINE MESYLATE (DIHYDROERGOTAMINE MESYLATE)